In a breakthrough in Alzheimer's disease research, American doctors have converted a simple eye test into a powerful diagnostic instrument for the disease (Science, Vol 266, No 5187).
A research team led by Leonard Scinto and Huntington Potter of the Harvard Medical School, Boston, reports that the pupils of Alzheimer's patients dilate more pronouncedly -- 13 per cent or more -- in response to drops of tropicamide, which doctors use in routine eye examinations, compared to about 5 per cent observed in healthy elderly people. The scientists claim that their test may be able to predict potential victims even before the symptoms develop.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.